Literature DB >> 9379829

The neuropeptide Y (Y4) receptor is highly expressed in neurones of the rat dorsal vagal complex.

P J Larsen1, P Kristensen.   

Abstract

Recently, the cDNA encoding the Y4 neuropeptide Y (NPY) receptor cDNA was cloned from a rat genomic library. The Y4 receptor is characterized by having a high affinity for pancreatic polypeptide (PP) and peptide YY (PYY). By using in situ hybridization histochemistry with 35S-labelled riboprobes, we have visualized the cellular expression of mRNA encoding the Y4 receptor protein in the rat dorsal vagal complex at the light microscopical level. High densities of silver grains were observed over neurones of the dorsal vagal motor nucleus, and over neurones of a subregion of the nucleus of the solitary tract known as the subnucleus gelatinosus. Furthermore, cells within the ventral margin of the area postrema expressed high levels of Y4 mRNA. These observations indicate that circulating PP and/or NPY/PYY via the blood-brain barrier-free area postrema and subpostremal area could influence neurones of the dorsal vagal complex with profound influence on numerous homeostatic mechanisms governed by this nuclear complex.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379829     DOI: 10.1016/s0169-328x(97)00069-7

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  13 in total

1.  [(125)I]-GR231118: a high affinity radioligand to investigate neuropeptide Y Y(1) and Y(4) receptors.

Authors:  Y Dumont; R Quirion
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 2.  Gut hormones as potential new targets for appetite regulation and the treatment of obesity.

Authors:  Benjamin C T Field; Alison M Wren; Dunstan Cooke; Stephen R Bloom
Journal:  Drugs       Date:  2008       Impact factor: 9.546

Review 3.  Gastrointestinal hormones regulating appetite.

Authors:  Owais Chaudhri; Caroline Small; Steve Bloom
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

4.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 5.  Regulation of appetite to treat obesity.

Authors:  Gilbert W Kim; Jieru E Lin; Michael A Valentino; Francheska Colon-Gonzalez; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2011-03       Impact factor: 5.045

6.  Current trends in targeting the hormonal regulation of appetite and energy balance to treat obesity.

Authors:  Michael A Valentino; Francheska Colon-Gonzalez; Jieru E Lin; Scott A Waldman
Journal:  Expert Rev Endocrinol Metab       Date:  2010-09-01

7.  Plasma NPY concentrations during tryptophan and sham depletion in medication-free patients with remitted depression.

Authors:  Christoph Czermak; Richard Hauger; Wayne C Drevets; David A Luckenbaugh; Marilla Geraci; Dennis S Charney; Alexander Neumeister
Journal:  J Affect Disord       Date:  2008-02-20       Impact factor: 4.839

8.  Synergistic effects of Y2 and Y4 receptors on adiposity and bone mass revealed in double knockout mice.

Authors:  Amanda Sainsbury; Paul A Baldock; Christoph Schwarzer; Naohiko Ueno; Ronaldo F Enriquez; Michelle Couzens; Akio Inui; Herbert Herzog; Edith M Gardiner
Journal:  Mol Cell Biol       Date:  2003-08       Impact factor: 4.272

9.  Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice.

Authors:  E Painsipp; T Wultsch; M E Edelsbrunner; R O Tasan; N Singewald; H Herzog; P Holzer
Journal:  Genes Brain Behav       Date:  2008-07       Impact factor: 3.449

10.  Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors.

Authors:  T Wultsch; E Painsipp; C K Thoeringer; H Herzog; G Sperk; P Holzer
Journal:  Neuroscience       Date:  2005-10-10       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.